Vivalis and Fort Dodge Animal Health sign a commercial license agreement to use the EB66 cell line for viral vaccines production.

Vivalis and Fort Dodge Animal Health, a division of Wyeth, announced the signing of a commercial license to use the EB66 cell line, a proprietary product of Vivalis, for the production of several veterinary vaccines. EB66 cell line, derived from duck embryonic stem cells, presents unique industrial and regulatory characteristics such as long-term genetic stability, immortality and cell growth to high cell densities in suspension in a serum-free …